PaccMann/paccmann_kinase_binding_residues

Comparison of active site and full kinase sequences for drug-target affinity prediction and molecular generation. Full paper: https://pubs.acs.org/doi/10.1021/acs.jcim.1c00889

35
/ 100
Emerging

This project helps drug discovery scientists accurately predict how strongly a potential drug molecule will bind to a kinase protein. By focusing on the kinase's active site protein sequence rather than its full sequence, it takes in active site sequences and molecular structures to output a binding affinity prediction. Medicinal chemists and computational biologists focused on kinase inhibitor design would use this.

No commits in the last 6 months.

Use this if you are developing new drug candidates and need to predict their binding affinity to kinases, especially when looking to optimize for specific active site interactions.

Not ideal if your primary interest is in designing molecules for non-kinase protein targets or if you need to model protein interactions beyond binding affinity.

drug-discovery medicinal-chemistry kinase-inhibitors protein-ligand-binding molecular-design
Stale 6m No Package No Dependents
Maintenance 0 / 25
Adoption 7 / 25
Maturity 16 / 25
Community 12 / 25

How are scores calculated?

Stars

37

Forks

5

Language

Python

License

MIT

Last pushed

Oct 03, 2022

Commits (30d)

0

Get this data via API

curl "https://pt-edge.onrender.com/api/v1/quality/ml-frameworks/PaccMann/paccmann_kinase_binding_residues"

Open to everyone — 100 requests/day, no key needed. Get a free key for 1,000/day.